GTC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Genes to Cells (2008) 13, 1061-1073. doi:10.1111/j.1365-2443.2008.01227.x
© 2008 Blackwell Publishing or its licensors

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kohno, T.
Right arrow Articles by Matsuyama, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kohno, T.
Right arrow Articles by Matsuyama, T.

Aberrant expression of BAFF receptor, a member of the tumor necrosis factor receptor family, in malignant cells of nonhematopoietic origins

Tomoko Kohno1, Tsutomu Daa2, Hiroshi Otani3, Isao Shimokawa3, Shigeo Yokoyama2 and Toshifumi Matsuyama1,*

1 Division of Cytokine Signaling, Department of Molecular Microbiology and Immunology, and
3 Department of Investigative Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8523 Japan
2 First Department of Pathology, Faculty of Medicine, Oita University, Yufu-city, Oita, 879-5593, Japan

The acquired capability of evading apoptosis is one of the prerequisites for cancer development, and NF-{kappa}B plays a critical role by inducing anti-apoptotic molecules. In this study, we firstly carried out an expression-cloning approach to isolate the responsible molecules in the NF-{kappa}B activation pathway with the defective mutant cell line, COS-A717. This cell line shows reduced constitutive basal activity of NF-{kappa}B as compared with the parental COS cells. We successfully isolated genes with compensating activity for the pathway, and one gene encoded B-cell activating factor receptor (BAFF-R). However, a Northern blot analysis revealed that the BAFF-R expression is not only limited to cells of B cell origin, but also is found in those with nonhematopoietic origins. In the human fibrosarcoma cell line HT1080, an immunohistochemical analysis revealed that the expression of BAFF-R is not on the cell surface, but in the cytoplasm. The expression of BAFF was also detected, and the reduction of endogenous BAFF or BAFF-R by siRNA decreased the basal NF-{kappa}B activity. Lastly, from clinicopathological specimens, the associated expression of BAFF-R and BAFF was demonstrated in osteosarcoma. We propose that an aberrant BAFF/BAFF-R-dependent autocrine mechanism may play a role in the development of certain types of cancer cells.


Communicated by: Shinichi Aizawa

* Correspondence: tosim{at}net.nagasaki-u.ac.jp







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
Copyright © 2008 by Wiley-Blackwell Publishing.